Loading...
Neuroprogressive and Dementia Network NHS Lothian | Our Services

iMarkHD

Investigating biomarkers for disease and symptom progression in Huntington’s disease

CHDI Foundation logo of  end of a neuron that makes it look like a tree

Project Details

Start Date
July 2022

Status
Open to Recruitment

Principal Investigator
Dr Peter Foley

NDN Study Lead
Jacqueline Kerr

Main Research Site
King’s College London

The NDN and NHS Lothian Huntington’s service, are helping to identify people who may be interested in taking part in the iMarkHD study.

This research study is trying to better understand the changes in the brain that happen when a person has Huntington’s disease.

This study is based at King’s College London.

What Happens In This Study?

You will have two types of imaging scans; one called Positron Emission Tomography (PET) and another called Magnetic Resonance Imaging (MRI), as well as taking part in several physical and cognitive assessments, and blood tests.

Can I Join This Study?

To take part in this research study, you must also meet these 4 requirements:

  1. Your Diagnosis: Both people with and without, either a diagnosis of HD OR carrying the HD gene mutation, can take part. 
  2. Your Age: You are between 21 and 75 years old.
  3. Your Permission: You must be able to understand what happens in the study and sign a form (called informed consent) to say you agree to join.
  4. Your Time: This study is based at King’s College London. You must do your best to attend all your study visits, and follow the rules of the study until it ends.

Study Length: 3 years

Number of appointments: 10 visits

More information on the trial can be found by contacting us at loth.sdcrn@nhs.scot or by calling 0131 537 3804.

a man in an orange t shirt
NDN Principal Investigator: Dr Peter Foley
a woman with light brown hair standing under a tree in a graduation gown
NDN Study Lead: Jacqueline Kerr

To find out more about this research study, please contact:
loth.sdcrn@nhs.scot
0131 537 3804

CHDI Foundation logo
King's College London logo

CONTACT INFORMATION

Neuroprogressive & Dementia Research Network Office

Old Pharmacy Building
Western General Hospital
Edinburgh
EH4 2XU

Email: loth.sdcrn@nhs.scot

Telephone: 0131 537 3804

ABOUT US

The NRS Neuroprogressive Disease and Dementia Network team in NHS Lothian conduct commercial and investigator led studies for: Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Motor Neurone Disease, dementia with Lewy bodies, Progressive Supranuclear Palsy and Multiple System Atrophy.

© NHS LOTHIAN | YOUR SERVICE.